Cite
JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice.
MLA
Bizzarri, Francesco, et al. “JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice.” Diagnostics (2075-4418), vol. 14, no. 10, May 2024, p. 988. EBSCOhost, https://doi.org/10.3390/diagnostics14100988.
APA
Bizzarri, F., Ruiz-Villaverde, R., Morales-Garrido, P., Ruiz-Carrascosa, J. C., Cebolla-Verdugo, M., Prados-Carmona, A., Rodriguez-Troncoso, M., & Raya-Alvarez, E. (2024). JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice. Diagnostics (2075-4418), 14(10), 988. https://doi.org/10.3390/diagnostics14100988
Chicago
Bizzarri, Francesco, Ricardo Ruiz-Villaverde, Pilar Morales-Garrido, Jose Carlos Ruiz-Carrascosa, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, Mar Rodriguez-Troncoso, and Enrique Raya-Alvarez. 2024. “JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice.” Diagnostics (2075-4418) 14 (10): 988. doi:10.3390/diagnostics14100988.